شنبه ١٠ آبان ١٣٩٩
 


Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial
Background: The clinical presentation of SARS-CoV-2 infection ranges from mild symptoms to severe complications, including acute respiratory distress syndrome. In this syndrome, inflammatory cytokines are released after activation of the...
 ١٣٩٩/٠٧/١٥ - نظرات : ٠متن کامل >>
A fourteen-day experience with coronavirus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS): An Iranian treatment protocol
COVID-19 is currently causing concern in the medical community as the virus is spreading around the world. It has a heavy global...
 ١٣٩٩/٠٧/١٥ - نظرات : ٠متن کامل >>
Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population
Background: The introduction of direct acting antivirals (DAAs) for hepatitis C virus (HCV) treatment promises shorter treatment duration, higher cure rates and fewer...
 ١٣٩٩/٠٤/٢٦ - نظرات : ٠متن کامل >>

2 3 4 5 6 7 8 9 10 صفحه بعدی >>





Copyright © 2013 CTERC.SBMU.AC.IR Allright Reserved   Powered By NRITLD IT Department